Vestal Point Capital, LP
Filing Date
Global Rank
#828
/ 8,603
▲ 125
· as of Mar 2026
Top Industry
Biotechnology
75.4%
3Y Alpha vs SPY
+15.5%
Period ended 3 months ago
Filed May 15, 2026 · 55d
10 quarters · since Dec 2023
Clone Performance
Feb 2024–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+108.2%
SPY
+53.6%
Annualised alpha
+16.2%
Max drawdown
−31.4%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
90 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
6.5%
−2.3 pts
Top 5
25.4%
−9.5 pts
Top 10
40.4%
−9.9 pts
HHI
255
Diversified−111
Portfolio Trend
10 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $3,576,817,338 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| BCRX | Biocryst Pharmaceuticals Inc | +4,775,000 | 7,025,000 | $66,878,000 | |
| TSHA | Taysha Gene Therapies, Inc. | +4,250,000 | 18,000,000 | $80,460,000 | |
| DYN | Dyne Therapeutics, Inc. | +3,880,000 | 4,000,000 | $72,520,000 | |
| GLUE | Monte Rosa Therapeutics, Inc. | +2,828,465 | 3,603,465 | $59,276,999 | |
| IMCR | Immunocore Holdings plc | +2,181,868 | 2,766,868 | $83,421,070 | |
| RVMD | Revolution Medicines, Inc. | +2,080,000 | 2,375,000 | $230,968,750 | |
| BCAX | Bicara Therapeutics Inc. | +1,850,000 | 5,425,000 | $107,903,250 | |
| NRIX | Nurix Therapeutics, Inc. | +1,810,000 | 6,500,000 | $100,750,000 | |
| BBNX | Beta Bionics, Inc. | +1,611,518 | 2,211,518 | $22,159,410 | |
| VYGR | Voyager Therapeutics, Inc. | +1,527,936 | 3,002,936 | $11,591,332 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | +1,375,000 | 2,275,000 | $142,642,500 | |
| DNLI | Denali Therapeutics Inc. | +1,308,326 | 1,773,326 | $34,047,859 | |
| OKUR | OnKure Therapeutics, Inc. | +1,204,819 | 1,839,819 | $7,616,850 | |
| ENGN | enGene Therapeutics Inc. | +1,110,000 | 2,165,000 | $14,743,650 | |
| SVRA | Savara Inc | +994,052 | 2,600,052 | $14,196,283 | |
| RGEN | Repligen Corp | +842,000 | 925,000 | $108,983,500 | |
| VERA | Vera Therapeutics, Inc. | +818,159 | 1,368,159 | $55,041,036 | |
| BMY | Bristol Myers Squibb Co | +750,000 | 1,000,000 | $60,650,000 | |
| SRRK | Scholar Rock Holding Corp | +624,422 | 1,324,422 | $65,108,585 | |
| BMRN | Biomarin Pharmaceutical Inc | +575,000 | 3,575,000 | $201,951,750 | |
| APGE | Apogee Therapeutics, Inc. | +550,000 | 1,100,000 | $92,587,000 | |
| NUVL | Nuvalent, Inc. | +435,715 | 481,715 | $49,351,701 | |
| MYGN | Myriad Genetics Inc | +425,000 | 1,648,000 | $7,416,000 | |
| RAPP | Rapport Therapeutics, Inc. | +326,229 | 1,436,229 | $44,939,605 | |
| ASND | Ascendis Pharma A/S | +200,000 | 375,000 | $85,773,750 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
14 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| GERN | Geron Corp | −8,780,000 | 2,540,000 | $3,784,600 | |
| TERN | Terns Pharmaceuticals, Inc. | −3,500,000 | 1,000,000 | $52,720,000 | |
| TYRA | Tyra Biosciences, Inc. | −2,371,000 | 54,000 | $2,068,200 | |
| OLMA | Olema Pharmaceuticals, Inc. | −1,221,449 | 428,551 | $6,389,695 | |
| SLDB | Solid Biosciences Inc. | −815,000 | 5,000,000 | $36,000,000 | |
| GMED | Globus Medical Inc | −664,480 | 610,520 | $52,602,403 | |
| ELVN | Enliven Therapeutics, Inc. | −580,000 | 3,250,000 | $127,400,000 | |
| ANRO | Alto Neuroscience, Inc. | −420,925 | 2,064,075 | $46,400,406 | |
| ABVX | Abivax S.A. | −400,000 | 1,500,000 | $167,025,000 | |
| ALC | Alcon Inc | −305,000 | 800,000 | $60,280,000 | |
| NVCR | NovoCure Ltd | −275,000 | 250,000 | $2,725,000 | |
| NYXH | Nyxoah SA | −238,339 | 868,661 | $2,536,490 | |
| KALV | KalVista Pharmaceuticals, Inc. | −40,000 | 1,850,000 | $37,240,500 | |
| IRON | Disc Medicine, Inc. | −35,000 | 700,000 | $44,758,000 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| NBIX | Neurocrine Biosciences Inc | 1,250,000 | $164,675,000 | |
| SNY | Sanofi | 1,400,000 | $67,452,000 | |
| BSX | Boston Scientific Corp | 800,000 | $50,200,000 | |
| COGT | Cogent Biosciences, Inc. | 1,230,888 | $47,376,879 | |
| UTHR | UNITED THERAPEUTICS Corp | 75,000 | $44,473,500 | |
| DRUG | Bright Minds Biosciences Inc. | 492,319 | $35,924,517 | |
| PTGX | Protagonist Therapeutics, Inc | 326,159 | $34,377,158 | |
| REGN | Regeneron Pharmaceuticals, Inc. | 40,000 | $30,905,600 | |
| WAT | Waters Corp /De/ | 100,000 | $29,780,000 | |
| VKTX | Viking Therapeutics, Inc. | 914,147 | $29,746,343 | |
| INSP | Inspire Medical Systems, Inc. | 539,269 | $27,815,495 | |
| TRVI | Trevi Therapeutics, Inc. | 2,166,504 | $25,846,392 | |
| SLNO | Soleno Therapeutics Inc | 730,000 | $24,440,400 | |
| NKTR | Nektar Therapeutics | 285,000 | $20,505,750 | |
| CYTK | Cytokinetics Inc | 300,000 | $19,773,000 | |
| AZN | Astrazeneca PLC | 100,000 | $19,722,000 | |
| WST | West Pharmaceutical Services Inc | 75,000 | $18,798,000 | |
| GEHC | GE HealthCare Technologies Inc. | 250,000 | $17,795,000 | |
| SGP | SpyGlass Pharma, Inc. | 666,760 | $17,275,751 | |
| MDGL | Madrigal Pharmaceuticals, Inc. | 31,468 | $16,472,553 | |
| WGS | GeneDx Holdings Corp. | 250,000 | $16,055,000 | |
| DMRA | Damora Therapeutics, Inc. | 600,000 | $15,540,000 | |
| TARS | Tarsus Pharmaceuticals, Inc. | 200,000 | $14,030,000 | |
| PODD | Insulet Corp | 50,601 | $10,618,113 | |
| SRZN | Surrozen, Inc./DE | 338,611 | $9,863,738 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
22 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| QQQ | Invesco Qqq Trust, Series 1 | 350,000 | $215,008,500 | |
| ACLX | Arcellx, Inc. | 2,925,000 | $190,710,000 | |
| DXCM | Dexcom Inc | 1,275,000 | $84,621,750 | |
| MRK | Merck & Co., Inc. | 775,000 | $81,576,500 | |
| ABT | Abbott Laboratories | 600,000 | $75,174,000 | |
| JAZZ | Jazz Pharmaceuticals plc | 290,000 | $49,300,000 | |
| DAWN | Day One Biopharmaceuticals, Inc. | 5,200,000 | $48,464,000 | |
| AXSM | Axsome Therapeutics, Inc. | 210,000 | $38,354,400 | |
| LNTH | Lantheus Holdings, Inc. | 360,000 | $23,958,000 | |
| ZYME | Zymeworks Inc. | 865,000 | $22,775,450 | |
| UPB | Upstream Bio, Inc. | 720,000 | $19,548,000 | |
| PEN | Penumbra Inc | 50,000 | $15,545,500 | |
| GILD | Gilead Sciences, Inc. | 50,000 | $6,137,000 | |
| DBVT | DBV Technologies S.A. | 300,000 | $5,751,000 | |
| MIRM | Mirum Pharmaceuticals, Inc. | 66,000 | $5,213,340 | |
| LENZ | LENZ Therapeutics, Inc. | 275,000 | $4,400,000 | |
| RZLT | Rezolute, Inc. | 1,686,000 | $3,978,960 | |
| STRO | Sutro Biopharma, Inc. | 243,000 | $2,811,510 | |
| GPCR | Structure Therapeutics Inc. | 35,000 | $2,434,250 | |
| BDTX | Black Diamond Therapeutics, Inc. | 870,000 | $2,114,100 | |
| FATE | Fate Therapeutics Inc | 1,725,000 | $1,690,500 | |
| ALEC | Alector, Inc. | 755,000 | $1,177,800 | |
| No positions match the current search. | ||||
90 positions ·
$3,576,817,338 total
· as of Mar 31, 2026
Showing 1–50
of 90 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Added | 2,375,000 | $230,968,750 | 6.46% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Added | 3,575,000 | $201,951,750 | 5.65% | |
| ABVX |
Abivax S.A.
Healthcare
|
Reduced | 1,500,000 | $167,025,000 | 4.67% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
NEW | 1,250,000 | $164,675,000 | 4.60% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
Added | 2,275,000 | $142,642,500 | 3.99% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
Reduced | 3,250,000 | $127,400,000 | 3.56% | |
| RGEN |
Repligen Corp
Healthcare
|
Added | 925,000 | $108,983,500 | 3.05% | |
| BCAX |
Bicara Therapeutics Inc.
Healthcare
|
Added | 5,425,000 | $107,903,250 | 3.02% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Added | 6,500,000 | $100,750,000 | 2.82% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
Added | 1,100,000 | $92,587,000 | 2.59% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Added | 375,000 | $85,773,750 | 2.40% | |
| IMCR |
Immunocore Holdings plc
Healthcare
|
Added | 2,766,868 | $83,421,070 | 2.33% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
Added | 18,000,000 | $80,460,000 | 2.25% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Added | 4,000,000 | $72,520,000 | 2.03% | |
| SNY |
Sanofi
Healthcare
|
NEW | 1,400,000 | $67,452,000 | 1.89% | |
| BCRX |
Biocryst Pharmaceuticals Inc
Healthcare
|
Added | 7,025,000 | $66,878,000 | 1.87% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Added | 1,324,422 | $65,108,585 | 1.82% | |
| IMTX |
Immatics N.V.
Healthcare
|
Added | 6,175,000 | $60,762,000 | 1.70% | |
| BMY |
Bristol Myers Squibb Co
Healthcare
|
Added | 1,000,000 | $60,650,000 | 1.70% | |
| ALC |
Alcon Inc
Healthcare
|
Reduced | 800,000 | $60,280,000 | 1.69% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
Added | 3,603,465 | $59,276,999 | 1.66% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Added | 1,368,159 | $55,041,036 | 1.54% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
Reduced | 1,000,000 | $52,720,000 | 1.47% | |
| GMED |
Globus Medical Inc
Healthcare
|
Reduced | 610,520 | $52,602,403 | 1.47% | |
| BSX |
Boston Scientific Corp
Healthcare
|
NEW | 800,000 | $50,200,000 | 1.40% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
Added | 481,715 | $49,351,701 | 1.38% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
NEW | 1,230,888 | $47,376,879 | 1.32% | |
| ANRO |
Alto Neuroscience, Inc.
Healthcare
|
Reduced | 2,064,075 | $46,400,406 | 1.30% | |
| RAPP |
Rapport Therapeutics, Inc.
Healthcare
|
Added | 1,436,229 | $44,939,605 | 1.26% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Reduced | 700,000 | $44,758,000 | 1.25% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
NEW | 75,000 | $44,473,500 | 1.24% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Added | 1,224,165 | $38,830,513 | 1.09% | |
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
Reduced | 1,850,000 | $37,240,500 | 1.04% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Added | 639,900 | $37,210,185 | 1.04% | |
| SLDB |
Solid Biosciences Inc.
Healthcare
|
Reduced | 5,000,000 | $36,000,000 | 1.01% | |
| DRUG |
Bright Minds Biosciences Inc.
Healthcare
|
NEW | 492,319 | $35,924,517 | 1.00% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
NEW | 326,159 | $34,377,158 | 0.96% | |
| DNLI |
Denali Therapeutics Inc.
Healthcare
|
Added | 1,773,326 | $34,047,859 | 0.95% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
NEW | 40,000 | $30,905,600 | 0.86% | |
| WAT |
Waters Corp /De/
Healthcare
|
NEW | 100,000 | $29,780,000 | 0.83% | |
| VKTX |
Viking Therapeutics, Inc.
Healthcare
|
NEW | 914,147 | $29,746,343 | 0.83% | |
| INSP |
Inspire Medical Systems, Inc.
Healthcare
|
NEW | 539,269 | $27,815,495 | 0.78% | |
| CBIO |
Crescent Biopharma, Inc.
Healthcare
|
Held | 1,500,000 | $27,555,000 | 0.77% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
NEW | 2,166,504 | $25,846,392 | 0.72% | |
| LXEO |
Lexeo Therapeutics, Inc.
Healthcare
|
Held | 4,475,000 | $25,686,500 | 0.72% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
NEW | 730,000 | $24,440,400 | 0.68% | |
| BBNX |
Beta Bionics, Inc.
Healthcare
|
Added | 2,211,518 | $22,159,410 | 0.62% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
NEW | 285,000 | $20,505,750 | 0.57% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
NEW | 300,000 | $19,773,000 | 0.55% | |
| AZN |
Astrazeneca PLC
Healthcare
|
NEW | 100,000 | $19,722,000 | 0.55% |